An integrated cell and medium engineering approach for production of a nanobody fusion in Saccharomyces cerevisiae
Abstract Saccharomyces cerevisiae is an established production host for therapeutic proteins; many of those are small proteins such as insulin or glucagon-like peptide-1 (GLP-1) analogs. Contrastingly, proteins of higher molecular weight, foremost antibodies, did not reach the market due, among othe...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer
2026-01-01
|
| Col·lecció: | Applied Microbiology and Biotechnology |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1007/s00253-025-13700-1 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|